Cargando…
Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug
Chemotherapy is a powerful cancer treatment but suffers from poor biocompatibility and a lack of tumor targeting. Here, we developed a CD44-targeted polymeric nanocomplex by encapsulating 10-hydroxycamptothecin (HCPT) into hyaluronic acid nanoparticles (HANP) for targeted cancer therapy. In vitro, t...
Autores principales: | Chen, Minglong, Zhang, Wenqi, Yuan, Kai, Bo, Mingxiang, Chen, Bin, Li, Lu, Ma, Qingjie, Zhu, Lei, Gao, Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612705/ https://www.ncbi.nlm.nih.gov/pubmed/29097925 http://dx.doi.org/10.1155/2017/4972701 |
Ejemplares similares
-
Engineered protein nanodrug as an emerging therapeutic tool
por: Li, Yuanxin, et al.
Publicado: (2022) -
Nanodrugs: pharmacokinetics and safety
por: Onoue, Satomi, et al.
Publicado: (2014) -
Nanodrugs Detonate Lysosome Bombs
por: Xiang, Yuting, et al.
Publicado: (2022) -
Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug
por: Wang, Xiaonan, et al.
Publicado: (2023) -
Big Data Analysis of Manufacturing and Preclinical Studies of Nanodrug-Targeted Delivery Systems: A Literature Review
por: Cao, Qiang, et al.
Publicado: (2022)